Cerebrovascular and Neurological Disorders: Protective Role of NRF2.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jul 2019
Historique:
received: 13 06 2019
revised: 05 07 2019
accepted: 06 07 2019
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 28 12 2019
Statut: epublish

Résumé

Cellular defense mechanisms, intracellular signaling, and physiological functions are regulated by electrophiles and reactive oxygen species (ROS). Recent works strongly considered imbalanced ROS and electrophile overabundance as the leading cause of cellular and tissue damage, whereas oxidative stress (OS) plays a crucial role for the onset and progression of major cerebrovascular and neurodegenerative pathologies. These include Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), stroke, and aging. Nuclear factor erythroid 2-related factor (NRF2) is the major modulator of the xenobiotic-activated receptor (XAR) and is accountable for activating the antioxidative response elements (ARE)-pathway modulating the detoxification and antioxidative responses of the cells. NRF2 activity, however, is also implicated in carcinogenesis protection, stem cells regulation, anti-inflammation, anti-aging, and so forth. Herein, we briefly describe the NRF2-ARE pathway and provide a review analysis of its functioning and system integration as well as its role in major CNS disorders. We also discuss NRF2-based therapeutic approaches for the treatment of neurodegenerative and cerebrovascular disorders.

Identifiants

pubmed: 31336872
pii: ijms20143433
doi: 10.3390/ijms20143433
pmc: PMC6678730
pii:
doi:

Substances chimiques

Biomarkers 0
NF-E2-Related Factor 2 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA029121
Pays : United States
Organisme : NIDA NIH HHS
ID : 2R01-DA029121
Pays : United States

Références

J Cereb Blood Flow Metab. 2000 Mar;20(3):592-603
pubmed: 10724123
Clin Ther. 2000 Oct;22(10):1151-68; discussion 1149-50
pubmed: 11110228
J Biol Chem. 2001 Aug 10;276(32):30188-98
pubmed: 11402028
J Biol Chem. 2003 Sep 26;278(39):37948-56
pubmed: 12842875
J Immunol. 2004 Mar 15;172(6):3553-63
pubmed: 15004156
J Biol Chem. 2006 May 26;281(21):14841-51
pubmed: 16551619
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):1021-36
pubmed: 16633893
J Neuropathol Exp Neurol. 2007 Jan;66(1):75-85
pubmed: 17204939
J Neurosci. 2007 Sep 19;27(38):10240-8
pubmed: 17881530
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2627-33
pubmed: 17916771
J Neurosci. 2008 Feb 13;28(7):1649-58
pubmed: 18272685
J Immunol. 2008 Jul 1;181(1):680-9
pubmed: 18566435
J Neuropathol Exp Neurol. 2008 Nov;67(11):1055-62
pubmed: 18957896
J Immunol. 2008 Nov 15;181(10):6730-7
pubmed: 18981090
Curr Opin Neurol. 2009 Jun;22(3):308-14
pubmed: 19359988
J Neurochem. 2009 Aug;110(3):1107-19
pubmed: 19558456
Glia. 2010 Apr;58(5):588-98
pubmed: 19908287
Inflamm Res. 2010 Jun;59(6):443-50
pubmed: 19924513
J Neurosci Res. 2010 May 1;88(6):1355-63
pubmed: 19998483
Biochimie. 2010 Mar;92(3):245-53
pubmed: 20026169
Nat Cell Biol. 2010 Mar;12(3):213-23
pubmed: 20173742
Free Radic Biol Med. 2010 Jul 15;49(2):147-58
pubmed: 20338236
Antioxid Redox Signal. 2010 Dec 1;13(11):1649-63
pubmed: 20367496
Physiol Rev. 2010 Apr;90(2):465-94
pubmed: 20393191
J Biol Chem. 2010 Jul 23;285(30):23064-74
pubmed: 20484052
Ann N Y Acad Sci. 2010 Oct;1207:32-40
pubmed: 20955423
Proc Am Thorac Soc. 2010 Nov;7(6):368-75
pubmed: 21030515
Free Radic Biol Med. 2011 Feb 1;50(3):428-37
pubmed: 21130160
Mol Cell Biol. 2011 Mar;31(6):1121-33
pubmed: 21245377
J Neurosci Res. 2011 Apr;89(4):515-23
pubmed: 21259333
Arch Biochem Biophys. 2011 Apr 1;508(1):101-9
pubmed: 21303654
Toxicol In Vitro. 2011 Jun;25(4):839-47
pubmed: 21333731
Arch Toxicol. 2011 Apr;85(4):241-72
pubmed: 21365312
Parkinsons Dis. 2011 Feb 22;2011:314082
pubmed: 21403858
J Biol Chem. 2011 May 6;286(18):16374-85
pubmed: 21454555
J Physiol. 2011 Sep 1;589(17):4125-36
pubmed: 21646410
Dis Model Mech. 2011 Sep;4(5):701-7
pubmed: 21719443
Int J Dev Biol. 2011;55(4-5):467-76
pubmed: 21769778
Neurochem Res. 2011 Dec;36(12):2352-62
pubmed: 21850487
J Biol Chem. 2011 Dec 30;286(52):44512-20
pubmed: 21984825
Free Radic Biol Med. 2012 Feb 1;52(3):539-555
pubmed: 22080087
Prog Neurobiol. 2012 Jan;96(1):87-95
pubmed: 22138392
Biochim Biophys Acta. 2012 May;1822(5):822-9
pubmed: 22206999
Free Radic Biol Med. 2012 Mar 1;52(5):928-36
pubmed: 22226832
J Biol Chem. 2012 Mar 23;287(13):9873-86
pubmed: 22275372
J Pineal Res. 2012 Sep;53(2):129-37
pubmed: 22304528
Neurosci Lett. 2012 Apr 11;514(1):46-50
pubmed: 22390900
J Neurosci. 2012 Mar 7;32(10):3462-73
pubmed: 22399769
Free Radic Biol Med. 2012 May 1;52(9):2038-46
pubmed: 22401859
Hum Mol Genet. 2012 Jul 1;21(13):2973-90
pubmed: 22492996
Hum Mol Genet. 2012 Jul 15;21(14):3173-92
pubmed: 22513881
Trends Mol Med. 2012 Jun;18(6):337-47
pubmed: 22578879
Neurochem Int. 2012 Aug;61(3):287-90
pubmed: 22609374
Chem Res Toxicol. 2012 Sep 17;25(9):1805-24
pubmed: 22686525
Free Radic Biol Med. 2012 Aug 15;53(4):817-27
pubmed: 22732183
Mol Cell Biol. 2012 Sep;32(17):3486-99
pubmed: 22751928
Cancer Cell. 2012 Jul 10;22(1):66-79
pubmed: 22789539
J Nutr Biochem. 2012 Oct;23(10):1201-6
pubmed: 22819548
J Clin Invest. 2012 Aug;122(8):2749-55
pubmed: 22850885
Antioxid Redox Signal. 2013 Mar 1;18(7):770-83
pubmed: 22867050
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13561-6
pubmed: 22872865
Oncogene. 2013 Aug 8;32(32):3765-81
pubmed: 22964642
Pharmacol Rev. 2012 Oct;64(4):1055-81
pubmed: 22966037
Free Radic Biol Med. 2012 Dec 1;53(11):2028-42
pubmed: 23000247
Folia Neuropathol. 2012;50(3):219-30
pubmed: 23023336
Neurol Res Int. 2012;2012:878030
pubmed: 23050144
Int J Mol Sci. 2012;13(9):11783-803
pubmed: 23109883
Biochem Pharmacol. 2013 Mar 15;85(6):705-17
pubmed: 23219527
J Neurosci. 2012 Dec 5;32(49):17775-87
pubmed: 23223297
J Neuropathol Exp Neurol. 2013 Jan;72(1):18-28
pubmed: 23242280
Amyloid. 2013 Mar;20(1):7-12
pubmed: 23253046
Brain Res. 2013 Feb 25;1497:32-9
pubmed: 23276496
Neurochem Int. 2013 Apr;62(5):764-75
pubmed: 23422879
Free Radic Biol Med. 2014 Jan;66:36-44
pubmed: 23434765
Int J Biochem Cell Biol. 2013 Jun;45(6):1019-30
pubmed: 23454680
PLoS One. 2013;8(3):e57932
pubmed: 23469253
J Alzheimers Dis. 2013;35(3):623-35
pubmed: 23478310
Free Radic Biol Med. 2013 Aug;61:438-52
pubmed: 23608463
Biochimie. 2013 Aug;95(8):1525-33
pubmed: 23643732
Brain Inj. 2013;27(7-8):924-33
pubmed: 23782269
Ophthalmol Eye Dis. 2011 Nov 03;3:45-54
pubmed: 23861623
Nat Chem Biol. 2013 Sep;9(9):586-92
pubmed: 23873212
Nat Commun. 2013;4:2192
pubmed: 23900241
Biol Open. 2013 Jun 20;2(8):761-70
pubmed: 23951401
Oxid Med Cell Longev. 2013;2013:415078
pubmed: 23983898
Mol Cell. 2013 Sep 12;51(5):618-31
pubmed: 24011591
Free Radic Biol Med. 2013 Dec;65:1012-1022
pubmed: 24017972
Redox Biol. 2013 Jan 18;1:45-9
pubmed: 24024136
Redox Biol. 2013 Feb 09;1:258-64
pubmed: 24024159
J Nutr Biochem. 2013 Dec;24(12):2127-37
pubmed: 24139673
Brain Res Bull. 2014 Jan;100:38-43
pubmed: 24252362
Neuropharmacology. 2014 Apr;79:298-306
pubmed: 24262633
Brain Res. 2014 Jan 28;1544:54-61
pubmed: 24333359
Curr Med Chem. 2014;21(18):2065-75
pubmed: 24372212
Mol Cell Biol. 2014 Mar;34(5):900-13
pubmed: 24379438
Biochim Biophys Acta. 2014 Aug;1842(8):1208-18
pubmed: 24382478
J Med Chem. 2014 Feb 27;57(4):1473-87
pubmed: 24467268
Brain Res. 2014 Apr 16;1558:90-9
pubmed: 24576487
J Cancer Res Clin Oncol. 2014 Aug;140(8):1251-9
pubmed: 24599821
Brain Behav Immun. 2014 Aug;40:131-42
pubmed: 24632338
Trends Biochem Sci. 2014 Apr;39(4):199-218
pubmed: 24647116
J Biol Chem. 2014 May 30;289(22):15244-58
pubmed: 24759106
Toxicol Appl Pharmacol. 2014 Jul 15;278(2):159-71
pubmed: 24793810
Free Radic Biol Med. 2014 Aug;73:1-11
pubmed: 24810171
J Neurosci. 2014 Jun 18;34(25):8585-93
pubmed: 24948812
J Neuroinflammation. 2014 Oct 15;11:177
pubmed: 25315906
Metab Brain Dis. 2015 Jun;30(3):747-54
pubmed: 25413451
Neurochem Res. 2015 Jan;40(1):186-94
pubmed: 25424966
PLoS One. 2014 Dec 10;9(12):e114573
pubmed: 25493642
J Pharmacovigil. 2014 Jun;2(2):125
pubmed: 25632404
Cell Mol Neurobiol. 2015 Jul;35(5):713-21
pubmed: 25732597
PLoS One. 2015 Mar 25;10(3):e0122358
pubmed: 25807533
Oxid Med Cell Longev. 2015;2015:370312
pubmed: 25918580
Free Radic Biol Med. 2015 Nov;88(Pt B):179-188
pubmed: 25975984
Free Radic Biol Med. 2015 Nov;88(Pt B):233-242
pubmed: 26051167
Free Radic Biol Med. 2015 Nov;88(Pt B):314-336
pubmed: 26066302
BMC Neurosci. 2015 Jun 23;16:38
pubmed: 26099276
Free Radic Biol Med. 2015 Nov;88(Pt B):93-100
pubmed: 26117331
Fluids Barriers CNS. 2015 Jul 24;12:18
pubmed: 26206552
FASEB J. 2016 Jan;30(1):66-80
pubmed: 26340923
Brain Res. 2015 Nov 19;1627:90-100
pubmed: 26410779
J Nutr Biochem. 2015 Dec;26(12):1401-13
pubmed: 26419687
Biochem J. 2015 Nov 1;471(3):307-22
pubmed: 26475449
Fluids Barriers CNS. 2015 Oct 31;12:25
pubmed: 26520792
Biochem Soc Trans. 2015 Aug;43(4):621-6
pubmed: 26551702
Pharmacol Ther. 2016 Jan;157:84-104
pubmed: 26617217
Microvasc Res. 2016 Jul;106:117-27
pubmed: 26686249
Neurobiol Dis. 2016 May;89:136-46
pubmed: 26850917
Semin Oncol. 2016 Feb;43(1):146-153
pubmed: 26970133
Antioxid Redox Signal. 2016 Jul 10;25(2):61-77
pubmed: 27009601
Tissue Barriers. 2015 Sep 11;4(1):e1090524
pubmed: 27141417
Drug Metab Rev. 2016 Nov;48(4):541-567
pubmed: 27320238
Vascul Pharmacol. 2016 Oct;85:29-38
pubmed: 27401964
Trends Pharmacol Sci. 2016 Sep;37(9):768-778
pubmed: 27491897
Brain Res. 2016 Dec 15;1653:1-7
pubmed: 27693416
J Pharmacol Exp Ther. 2017 Jan;360(1):201-205
pubmed: 27754930
Biomed Pharmacother. 2017 Jan;85:79-86
pubmed: 27930990
Free Radic Biol Med. 2017 Feb;103:155-164
pubmed: 28012783
J Biol Chem. 2017 Feb 3;292(5):2048
pubmed: 28159761
Int Immunopharmacol. 2017 Apr;45:74-78
pubmed: 28189971
Redox Biol. 2017 Aug;12:58-69
pubmed: 28212524
Front Neurol. 2017 Feb 20;8:28
pubmed: 28265255
Pharmacol Rep. 2017 Jun;69(3):393-402
pubmed: 28267640
Molecules. 2017 Mar 09;22(3):
pubmed: 28282941
Reprod Sci. 2017 Dec;24(12):1590-1599
pubmed: 28322133
Neurosci Lett. 2017 Jul 13;653:152-158
pubmed: 28572033
Pharm Res. 2017 Dec;34(12):2614-2627
pubmed: 28589443
Redox Biol. 2017 Oct;13:353-362
pubmed: 28646795
Redox Biol. 2017 Oct;13:444-451
pubmed: 28704727
Behav Brain Res. 2018 Jan 15;336:32-39
pubmed: 28851669
BMC Neurosci. 2017 Oct 4;18(1):70
pubmed: 28985714
Brain Behav Immun. 2018 Mar;69:351-363
pubmed: 29253574
Biochim Biophys Acta Mol Cell Res. 2018 May;1865(5):721-733
pubmed: 29499228
J Cereb Blood Flow Metab. 2019 Feb;39(2):352-366
pubmed: 29533123
Toxicol Appl Pharmacol. 2018 May 1;346:28-36
pubmed: 29571711
CNS Neurol Disord Drug Targets. 2018;17(3):207-215
pubmed: 29692267
Front Cell Neurosci. 2018 Apr 27;12:114
pubmed: 29755324
Neurosci Lett. 2018 Aug 24;682:1-9
pubmed: 29879439
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):853-863
pubmed: 29905772
Ageing Res Rev. 2018 Nov;47:31-40
pubmed: 29913211
Autophagy. 2018;14(8):1310-1322
pubmed: 29950142
FEBS Open Bio. 2018 May 18;8(7):1104-1118
pubmed: 29988567
Redox Biol. 2018 Sep;18:173-180
pubmed: 30029164
J Cereb Blood Flow Metab. 2018 Oct;38(10):1667-1681
pubmed: 30058456
Neurobiol Dis. 2019 Mar;123:27-41
pubmed: 30059725
Sci Rep. 2018 Aug 23;8(1):12708
pubmed: 30139948
Redox Biol. 2019 Feb;21:101059
pubmed: 30576920
Int J Neurosci. 2019 Aug;129(8):801-807
pubmed: 30648894
Neuroreport. 2019 Mar 20;30(5):344-349
pubmed: 30724850
Pharmacol Res. 2019 Apr;142:237-250
pubmed: 30818045
Front Pharmacol. 2019 Mar 05;10:153
pubmed: 30890934
Geroscience. 2019 Apr 2;:null
pubmed: 30941620
BMC Neurosci. 2019 Apr 04;20(1):15
pubmed: 30947684
Life Sci. 2019 Jun 15;227:101-113
pubmed: 31002919

Auteurs

Farzane Sivandzade (F)

Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.

Aditya Bhalerao (A)

Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.

Luca Cucullo (L)

Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA. luca.cucullo@ttuhsc.edu.
Center for Blood Brain Barrier Research, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA. luca.cucullo@ttuhsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH